Top Tweets for #ObstructiveHCM
@MartinMaronMD @IacopoOlivotto @harry_rakowski @MasriAhmadMD @HCMSummit The treatment landscape for #obstructiveHCM has never been more complex — or more promising. Looking forward to this discussion.
The treatment landscape for #obstructiveHCM has never been more complex — or more promising. See you in Boston. Oct 24 · https://t.co/XK17fomHys #HCM9
Myosin inhibitors changed everything. So what comes next?
Five experts. The hardest questions in obstructive #HCM — #CMI disease modification, non-responders, disopyramide, and what's on the horizon.
@IacopoOlivotto · Sara Saberi · @harry_rakowski · @MasriAhmadMD · Mark Sherrid
*Only 11 weeks* until International @HCMSummit 8. Don't miss #PremShekar's talk: "Operating on #ObstructiveHCM with Mild Septal Hypertrophy: Expanding the #Myectomy Spectrum." Secure your seat today at https://t.co/MBfMwmzyKO. #cardiotwitter #cardioed #hypertrophiccardiomyopathy
Continuing our #HeartFailure in #ObstructiveHCM discussion, @AWangDukeU presents, "What is the Evidence for #CardiacRemodeling w/ #MyosinInhibitors And Is It Different Than with #SeptalReduction Therapies?" Register at https://t.co/WmHdJIVBpp. #CardioTwitter #CardioEd #HCMSummit8
Next on the agenda for #HeartFailure in #ObstructiveHCM at @HCMSummit (Boston | Oct 25-27) is my event co-director @MartinMaronMD with his talk on what to expect from new #CardiacMyosinInhibitors. Learn more at https://t.co/XK17fonfo0. #CardioTwitter #CardioEd #HCMSummit8
My co-director @steveommen will kick off Day 2 of #HCMSummit8 with a talk on #heartfailure in #obstructiveHCM. We're less than 5 months away & seats are now very limited—register soon to secure your spot: https://t.co/MBfMwmz0Vg. #hcm #cardiotwitter #hypertrophiccardiomyopathy
Aficamten is a novel cardiac myosin inhibitor for the treatment of hypertrophic cardiomyopathy. Here come the related building blocks we can provide: https://t.co/QAOTtcGXFV 👇
#Chemenu #Aficamten #novel #cardiacmyosininhibitor #hypertrophiccardiomyopathy #obstructiveHCM
#ACC22 🔥Late-Breaking interview on the VALOR-HCM Trial | @DesaiMilindY
🔍Key findings for 👥 with obstructive HCM
💊Effect on clinical practice?
👉Take-home messages
🎥 Watch Now: https://t.co/ZcmBp6em9l
#CardioEd #MedEd #Cardiology #ClinicalStudy #ObstructiveHCM
My Commentary on #EXPLORER_HCM trial.
Learn more about thenew drug #Mavacamtem dedicated exclusively to #ObstructiveHCM pts without side-effect compared to traditional therapy
@SABOURETCardio @ShelleyZieroth @hvanspall @DrNasrien @DrMarthaGulati @AnastasiaSMihai @MicheleSenni
COMMENTARY by @GiuseppeGalati_ on EXPLORER-HCM Study: Efficacy & safety of mavacamten in adults with symptomatic obstructive hypertrophic cardiomyopathy.
🎥 https://t.co/d7gutvx6fy 👈
#ESCCongress #ESC2020 #EXPLORERHCM #Cardiology #Cardiotwitter
Last Seen Hashtags on Sotwe
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
240.2M followers
Barack Obama
@barackobama
119.3M followers
Donald J. Trump
@realdonaldtrump
111.6M followers
Cristiano Ronaldo
@cristiano
108.9M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.3M followers
NASA
@nasa
92.1M followers
Justin Bieber
@justinbieber
90.6M followers
KATY PERRY
@katyperry
86.8M followers
Taylor Swift
@taylorswift13
80.6M followers
Lady Gaga
@ladygaga
72.2M followers
Kim Kardashian
@kimkardashian
69.4M followers
YouTube
@youtube
68.6M followers
Virat Kohli
@imvkohli
68.5M followers
Bill Gates
@billgates
63.4M followers
The Ellen Show
@theellenshow
62.5M followers
CNN
@cnn
61.9M followers
Neymar Jr
@neymarjr
61.1M followers
X
@x
60.9M followers
Selena Gomez
@selenagomez
59.9M followers